Skip to main content
SGLT2i vs DPP4i tied with reduced mortality and HF readmission risk in T2D patients with HF
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
SGLT2i vs DPP4i tied with reduced mortality and HF readmission risk in T2D patients with HF
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
SGLT2 Inhibitor
0
0.63
Acute Heart Failure (HF)
0
0.52
Heart Failure (HF)
0
0.47
Diabetes Mellitus
0
0.32
DPP-4 Inhibitors
0
0.32
Geriatrics
0
0.32
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Cardiology
0
0.69
Edit Tags